Biocon Biologics Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2024-00201 filed by Biocon Biologics Inc. et al. on 2023-11-20. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2024-00201

Filing Date

2023-11-20

Accorded Filing Date

2023-11-20

Institution Decision Date

2024-01-16

Last Modified Date

2025-03-26

Proceeding Type

IPR

Termination Date

2024-07-30

Trial Status

Terminated-Adverse Judgment

Parties & Counsel

Petitioner

Biocon Biologics Inc. et al.

Represented By

Molino, Paulet al

Patent Owner / Respondent

Regeneron Pharmaceuticals, Inc.

Represented By

Brausa, Adamet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 16397267

Respondent Patent Number 10888601

External Links

Espacenet

Google Patents

Respondent Inventor George D. YANCOPOULOS

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

23 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name A&P - Regeneron (Prosecution)

Customer Number 191459

Address 601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
41408	David Marsh	202-942-5068
48001	Thomas Triolo	914-847-1612
48921	Stephen Gaudet	914-847-7376
50370	Neil Miyamoto	914-847-7175
50437	Frank Cottingham	914-593-1116
58583	Brian Cocca	914-847-1421
58714	Ilona Gont	914-847-1304
59668	Brandon Schurter	914-847-7000
60281	Aparna Patankar	914-847-5571
61391	Yonghao Hou	914-839-2555
61915	Yongjin Choi	914-847-5384
65789	Margarita Zippin	914-847-5589
65957	Lisa Flanagan	914-847-8175
67881	Eileen Woo	914-847-1246
68046	Elysa Goldberg	914-847-1280
68059	David Mellman	720-391-8767
68136	Christopher Westberg	914-847-7912
71406	Gabriele Amodeo	914-847-3578
73212	Trisha Agrawal	914-313-7694
74751	Casey Donahoe	814-931-8622
76829	Michael Lewis	202-942-6728
77536	Alyson Nickols	640-448-3073
81783	Alice Ho	202-942-6753

Proceeding Documents

Adverse judgment: post-institution ADVRSJUDG

2024-07-30 FILING PARTY: BOARD

Download

Petitioner's Amended Mandatory Notices NOTICE

2024-05-03 FILING PARTY: PETITIONER

Download

Petitioner's Amended Mandatory Notices NOTICE

2024-01-18 FILING PARTY: PETITIONER

Download

Institution Decision: Joined OTHER

2024-01-16 FILING PARTY: BOARD

Download

Patent Owner's Opposition to Petitioner's Motion for Joinder OPPOSITION

2023-12-20 FILING PARTY: PATENT OWNER

Download

Biocon Biologics Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

Proceeding Overview

Parties & Counsel

Petitioner

Biocon Biologics Inc. et al.

Represented By

Patent Owner / Respondent

Regeneron Pharmaceuticals, Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Adverse judgment: post-institution ADVRSJUDG

Petitioner's Amended Mandatory Notices NOTICE

Petitioner's Amended Mandatory Notices NOTICE

Institution Decision: Joined OTHER

Patent Owner's Opposition to Petitioner's Motion for Joinder OPPOSITION

Exhibit 2001 Exhibit

Exhibit 2002 Exhibit

Petitioner's Amended Mandatory Notices NOTICE

Notice : Power of Attorney NOTICE

Notice : Mandatory Notice NOTICE

Notice: Notice filing date accorded NOTICE

Petitioner's Amended Mandatory Notices NOTICE

NIH Macular Degeneration Exhibit

History of Changes NCT00090623 Exhibit

WO2012097019A1 Exhibit

Heier 2011 Exhibit

'601 patent Exhibit

The DA VINCI Study AAO Website Exhibit

'601 patent PH (1) Exhibit

DO Workshop 2009 Exhibit

338 Patent FWD Exhibit

Martin 2012 Exhibit

CATT Study Wayback Machine Affidavit Exhibit

Chaum Decl. Exhibit

Li 2020 Exhibit

Regeneron July 2023 Disclaimer (IPR2023-00739 Ex 2002) Exhibit

Rudge 2005 Exhibit

Eylea 2011 Label Exhibit

Lucentis 2006 Label Exhibit

Regeneron Sep 28 2008 Press Release Exhibit

'601 patent PH (2) Exhibit

PIER AJO Website Exhibit

NCT 00593450 Exhibit

About the Results Database - ClinicalTrials.gov Exhibit

Dixon Exhibit

Gomez Manzano Exhibit

MACTEL Wayback Machine Exhibit

ClinicalTrials.gov Background - ClinicalTrials.gov Exhibit

Elman 2010 Exhibit

Mylan Litigation Scheduling Order Exhibit

Using The Wayback Machine Internet Archive Help Center Exhibit

US7531173 Exhibit

'601 patent PH (4) Exhibit

Jaffe Exhibit

Petitioner Biocon Biologics Inc.'s Power of Attorney NOTICE

Do 2011 Exhibit

Holash Exhibit

Docket Navigator Exhibit

Elman AAO Webpage Exhibit

Samsung IPR Petition Exhibit

Rosenfeld 2006 Exhibit

US9254338 Exhibit

Regeneron Sep 14 2009 Press Release Exhibit

'601 patent PH (8) Exhibit

Pai 2010 Exhibit

Petitioner's Motion for Joinder MOTION

Samsung IPR POPR Exhibit

Heimann 2007 Exhibit

Chakravarthy 2012 Exhibit

'601 patent PH (6) Exhibit

Petitioner's Motion to Seal MOTION

601 FH (10) Exhibit

Steps for a Safe Intravitreal Injection Technique Exhibit

Eylea Label 2016 Exhibit

NIH Diabetic-Retinopathy-What-You-Should-Know Exhibit